Published in Oncol Rep on October 04, 2016
Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature (2007) 7.87
Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med (2001) 7.78
VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium. Cancer Cell (2012) 2.14
HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. BMC Biochem (2006) 2.09
Vascular endothelial growth factor receptors in the regulation of angiogenesis and lymphangiogenesis. Oncogene (2000) 1.96
Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate. Expert Opin Ther Targets (2010) 1.62
Tumor metastasis and the lymphatic vasculature. Int J Cancer (2009) 1.51
Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. Biochem J (2006) 1.48
Molecular lymphangiogenesis: new players. Trends Cell Biol (2005) 1.42
Lymphangiogenic growth factor responsiveness is modulated by postnatal lymphatic vessel maturation. Am J Pathol (2006) 1.39
PI3K/Akt and MAPK/ERK1/2 signaling pathways are involved in IGF-1-induced VEGF-C upregulation in breast cancer. J Cancer Res Clin Oncol (2011) 1.21
Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases. Clin Exp Metastasis (2008) 1.17
From angiogenesis to lymphangiogenesis. Nat Med (2001) 1.13
The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics. Front Oncol (2014) 1.08
HpSulf, a heparan sulfate 6-O-endosulfatase, is involved in the regulation of VEGF signaling during sea urchin development. Mech Dev (2009) 0.95
Role of heparan sulfatases in ovarian and breast cancer. Am J Cancer Res (2013) 0.95
Lymphangiogenesis in tumors: what do we know? Microsc Res Tech (2003) 0.90
Current trends of sentinel lymph node biopsy for breast cancer--a surgeon's perspective. Breast Cancer (2007) 0.90
The extent of retraction clefts correlates with lymphatic vessel density and VEGF-C expression and predicts nodal metastasis and poor prognosis in early-stage breast carcinoma. Mod Pathol (2011) 0.90
The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair. PLoS One (2013) 0.88
The propeptides of VEGF-D determine heparin binding, receptor heterodimerization, and effects on tumor biology. J Biol Chem (2013) 0.88
SULF2 Expression Is a Potential Diagnostic and Prognostic Marker in Lung Cancer. PLoS One (2016) 0.83
Gene expression profiling of circulating tumor cells in breast cancer. Clin Chem (2014) 0.83
SULF1/SULF2 splice variants differentially regulate pancreatic tumour growth progression. Exp Cell Res (2014) 0.83
Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines. Curr Oncol (2015) 0.82
Xenografts of human solid tumors frequently express cellular-associated isoform of vascular endothelial growth factor (VEGF) 189. Oncol Rep (1999) 0.81
Sulfatase 2 promotes breast cancer progression through regulating some tumor-related factors. Oncol Rep (2015) 0.80
Chemopreventive and hepatoprotective roles of adiponectin (SULF2 inhibitor) in hepatocelluar carcinoma. Biol Chem (2016) 0.78
Effects of VEGF121 and/or VEGF165 gene transfection on collateral circulation development. J Formos Med Assoc (2000) 0.77